{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T13:25:21Z","timestamp":1776086721779,"version":"3.50.1"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,3,23]],"date-time":"2019-03-23T00:00:00Z","timestamp":1553299200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s00467-019-04225-7","type":"journal-article","created":{"date-parts":[[2019,3,23]],"date-time":"2019-03-23T16:03:31Z","timestamp":1553357011000},"page":"569-579","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Treatment of nephrotic syndrome: going beyond immunosuppressive therapy"],"prefix":"10.1007","volume":"35","author":[{"given":"Jinghong","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,23]]},"reference":[{"key":"4225_CR1","first-page":"56","volume":"4","author":"A Pal","year":"2016","unstructured":"Pal A, Kaskel F (2016) History of nephrotic syndrome and evolution of its treatment. Front Pediatr 4:56","journal-title":"Front Pediatr"},{"key":"4225_CR2","doi-asserted-by":"crossref","unstructured":"(1984) Minimal change nephrotic syndrome in children: deaths during the first 5 to 15 years\u2019 observation. Report of the International Study of Kidney Disease in Children. Pediatrics 73:497\u2013501","DOI":"10.1542\/peds.73.4.497"},{"key":"4225_CR3","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1007\/s00467-009-1138-5","volume":"24","author":"D Mekahli","year":"2009","unstructured":"Mekahli D, Liutkus A, Ranchin B, Yu A, Bessenay L, Girardin E, Van Damme-Lombaerts R, Palcoux JB, Cachat F, Lavocat MP, Bourdat-Michel G, Nobili F, Cochat P (2009) Long-term outcome of idiopathic steroid-resistant nephrotic syndrome: a multicenter study. Pediatr Nephrol 24:1525\u20131532","journal-title":"Pediatr Nephrol"},{"key":"4225_CR4","doi-asserted-by":"crossref","unstructured":"(1978) Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. A report of the International Study of Kidney Disease in Children. Kidney Int 13:159\u2013165","DOI":"10.1038\/ki.1978.23"},{"key":"4225_CR5","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/nrneph.2016.147","volume":"12","author":"RJ Maas","year":"2016","unstructured":"Maas RJ, Deegens JK, Smeets B, Moeller MJ, Wetzels JF (2016) Minimal change disease and idiopathic FSGS: manifestations of the same disease. Nat Rev Nephrol 12:768\u2013776","journal-title":"Nat Rev Nephrol"},{"key":"4225_CR6","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1097-2765(00)80057-X","volume":"1","author":"M Kestila","year":"1998","unstructured":"Kestila M, Lenkkeri U, Mannikko M, Lamerdin J, McCready P, Putaala H, Ruotsalainen V, Morita T, Nissinen M, Herva R, Kashtan CE, Peltonen L, Holmberg C, Olsen A, Tryggvason K (1998) Positionally cloned gene for a novel glomerular protein\u2014nephrin\u2014is mutated in congenital nephrotic syndrome. Mol Cell 1:575\u2013582","journal-title":"Mol Cell"},{"key":"4225_CR7","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00467-017-3838-6","volume":"34","author":"R Preston","year":"2019","unstructured":"Preston R, Stuart HM, Lennon R (2019) Genetic testing in steroid-resistant nephrotic syndrome: why, who, when and how? Pediatr Nephrol 34:195\u2013210","journal-title":"Pediatr Nephrol"},{"key":"4225_CR8","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1053\/ajkd.2003.50116","volume":"41","author":"F Fakhouri","year":"2003","unstructured":"Fakhouri F, Bocquet N, Taupin P, Presne C, Gagnadoux MF, Landais P, Lesavre P, Chauveau D, Knebelmann B, Broyer M, Grunfeld JP, Niaudet P (2003) Steroid-sensitive nephrotic syndrome: from childhood to adulthood. Am J Kidney Dis 41:550\u2013557","journal-title":"Am J Kidney Dis"},{"key":"4225_CR9","doi-asserted-by":"crossref","unstructured":"(1981) Primary nephrotic syndrome in children: clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularity. A Report of the International Study of Kidney Disease in Children. Kidney Int 20:765\u2013771","DOI":"10.1038\/ki.1981.209"},{"key":"4225_CR10","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/adc.57.7.544","volume":"57","author":"O Koskimies","year":"1982","unstructured":"Koskimies O, Vilska J, Rapola J, Hallman N (1982) Long-term outcome of primary nephrotic syndrome. Arch Dis Child 57:544\u2013548","journal-title":"Arch Dis Child"},{"key":"4225_CR11","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1681\/ASN.V85769","volume":"8","author":"P Tarshish","year":"1997","unstructured":"Tarshish P, Tobin JN, Bernstein J, Edelmann CM Jr (1997) Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children. J Am Soc Nephrol 8:769\u2013776","journal-title":"J Am Soc Nephrol"},{"key":"4225_CR12","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00467-012-2310-x","volume":"28","author":"RM Lombel","year":"2013","unstructured":"Lombel RM, Gipson DS, Hodson EM, Kidney Disease: Improving Global Outcomes (2013) Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO. Pediatr Nephrol 28:415\u2013426","journal-title":"Pediatr Nephrol"},{"key":"4225_CR13","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00467-012-2310-x","volume":"28","author":"RM Lombel","year":"2013","unstructured":"Lombel RM, Hodson EM, Gipson DS, Kidney Disease: Improving Global Outcomes (2013) Treatment of steroid-resistant nephrotic syndrome in children: new guidelines from KDIGO. Pediatr Nephrol 28:415\u2013426","journal-title":"Pediatr Nephrol"},{"key":"4225_CR14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2147\/PHMT.S100803","volume":"8","author":"N Nourbakhsh","year":"2017","unstructured":"Nourbakhsh N, Mak RH (2017) Steroid-resistant nephrotic syndrome: past and current perspectives. Pediatric Health Med Ther 8:29\u201337","journal-title":"Pediatric Health Med Ther"},{"key":"4225_CR15","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S2352-4642(18)30283-9","volume":"2","author":"K Tullus","year":"2018","unstructured":"Tullus K, Webb H, Bagga A (2018) Management of steroid-resistant nephrotic syndrome in children and adolescents. Lancet Child Adolesc Health 2:880\u2013890","journal-title":"Lancet Child Adolesc Health"},{"key":"4225_CR16","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/sj.ki.5002222","volume":"71","author":"RC Wiggins","year":"2007","unstructured":"Wiggins RC (2007) The spectrum of podocytopathies: a unifying view of glomerular diseases. Kidney Int 71:1205\u20131214","journal-title":"Kidney Int"},{"key":"4225_CR17","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s00431-011-1668-2","volume":"171","author":"AK Buscher","year":"2012","unstructured":"Buscher AK, Weber S (2012) Educational paper: the podocytopathies. Eur J Pediatr 171:1151\u20131160","journal-title":"Eur J Pediatr"},{"key":"4225_CR18","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/sj.ki.5001679","volume":"70","author":"K Hasselbacher","year":"2006","unstructured":"Hasselbacher K, Wiggins RC, Matejas V, Hinkes BG, Mucha B, Hoskins BE, Ozaltin F, Nurnberg G, Becker C, Hangan D, Pohl M, Kuwertz-Broking E, Griebel M, Schumacher V, Royer-Pokora B, Bakkaloglu A, Nurnberg P, Zenker M, Hildebrandt F (2006) Recessive missense mutations in LAMB2 expand the clinical spectrum of LAMB2-associated disorders. Kidney Int 70:1008\u20131012","journal-title":"Kidney Int"},{"key":"4225_CR19","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1093\/ndt\/gfv355","volume":"31","author":"S Lovric","year":"2016","unstructured":"Lovric S, Ashraf S, Tan W, Hildebrandt F (2016) Genetic testing in steroid-resistant nephrotic syndrome: when and how? Nephrol Dial Transplant 31:1802\u20131813","journal-title":"Nephrol Dial Transplant"},{"key":"4225_CR20","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nrneph.2012.286","volume":"9","author":"RA Gbadegesin","year":"2013","unstructured":"Gbadegesin RA, Winn MP, Smoyer WE (2013) Genetic testing in nephrotic syndrome\u2014challenges and opportunities. Nat Rev Nephrol 9:179\u2013184","journal-title":"Nat Rev Nephrol"},{"key":"4225_CR21","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.ajhg.2014.04.010","volume":"94","author":"HY Gee","year":"2014","unstructured":"Gee HY, Ashraf S, Wan X, Vega-Warner V, Esteve-Rudd J, Lovric S, Fang H, Hurd TW, Sadowski CE, Allen SJ, Otto EA, Korkmaz E, Washburn J, Levy S, Williams DS, Bakkaloglu SA, Zolotnitskaya A, Ozaltin F, Zhou W, Hildebrandt F (2014) Mutations in EMP2 cause childhood-onset nephrotic syndrome. Am J Hum Genet 94:884\u2013890","journal-title":"Am J Hum Genet"},{"key":"4225_CR22","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1038\/s41467-018-04193-w","volume":"9","author":"S Ashraf","year":"2018","unstructured":"Ashraf S, Kudo H, Rao J, Kikuchi A, Widmeier E, Lawson JA, Tan W, Hermle T, Warejko JK, Shril S, Airik M, Jobst-Schwan T, Lovric S, Braun DA, Gee HY, Schapiro D, Majmundar AJ, Sadowski CE, Pabst WL, Daga A, van der Ven AT, Schmidt JM, Low BC, Gupta AB, Tripathi BK, Wong J, Campbell K, Metcalfe K, Schanze D, Niihori T, Kaito H, Nozu K, Tsukaguchi H, Tanaka R, Hamahira K, Kobayashi Y, Takizawa T, Funayama R, Nakayama K, Aoki Y, Kumagai N, Iijima K, Fehrenbach H, Kari JA, El Desoky S, Jalalah S, Bogdanovic R, Stajic N, Zappel H, Rakhmetova A, Wassmer SR, Jungraithmayr T, Strehlau J, Kumar AS, Bagga A, Soliman NA, Mane SM, Kaufman L, Lowy DR, Jairajpuri MA, Lifton RP, Pei Y, Zenker M, Kure S, Hildebrandt F (2018) Mutations in six nephrosis genes delineate a pathogenic pathway amenable to treatment. Nat Commun 9:1960","journal-title":"Nat Commun"},{"key":"4225_CR23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00467-014-2857-9","volume":"30","author":"MG Sampson","year":"2015","unstructured":"Sampson MG, Hodgin JB, Kretzler M (2015) Defining nephrotic syndrome from an integrative genomics perspective. Pediatr Nephrol 30:51\u201363 quiz 59","journal-title":"Pediatr Nephrol"},{"key":"4225_CR24","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrneph.2015.206","volume":"12","author":"HJ Anders","year":"2016","unstructured":"Anders HJ, Jayne DR, Rovin BH (2016) Hurdles to the introduction of new therapies for immune-mediated kidney diseases. Nat Rev Nephrol 12:205\u2013216","journal-title":"Nat Rev Nephrol"},{"key":"4225_CR25","doi-asserted-by":"crossref","first-page":"592","DOI":"10.2215\/CJN.06260614","volume":"10","author":"A Trautmann","year":"2015","unstructured":"Trautmann A, Bodria M, Ozaltin F, Gheisari A, Melk A, Azocar M, Anarat A, Caliskan S, Emma F, Gellermann J, Oh J, Baskin E, Ksiazek J, Remuzzi G, Erdogan O, Akman S, Dusek J, Davitaia T, Ozkaya O, Papachristou F, Firszt-Adamczyk A, Urasinski T, Testa S, Krmar RT, Hyla-Klekot L, Pasini A, Ozcakar ZB, Sallay P, Cakar N, Galanti M, Terzic J, Aoun B, Caldas Afonso A, Szymanik-Grzelak H, Lipska BS, Schnaidt S, Schaefer F, PodoNet Consortium (2015) Spectrum of steroid-resistant and congenital nephrotic syndrome in children: the PodoNet registry cohort. Clin J Am Soc Nephrol 10:592\u2013600","journal-title":"Clin J Am Soc Nephrol"},{"key":"4225_CR26","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.kint.2016.10.013","volume":"91","author":"A Bierzynska","year":"2017","unstructured":"Bierzynska A, McCarthy HJ, Soderquest K, Sen ES, Colby E, Ding WY, Nabhan MM, Kerecuk L, Hegde S, Hughes D, Marks S, Feather S, Jones C, Webb NJ, Ognjanovic M, Christian M, Gilbert RD, Sinha MD, Lord GM, Simpson M, Koziell AB, Welsh GI, Saleem MA (2017) Genomic and clinical profiling of a national nephrotic syndrome cohort advocates a precision medicine approach to disease management. Kidney Int 91:937\u2013947","journal-title":"Kidney Int"},{"key":"4225_CR27","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1681\/ASN.2013111155","volume":"26","author":"S Giglio","year":"2015","unstructured":"Giglio S, Provenzano A, Mazzinghi B, Becherucci F, Giunti L, Sansavini G, Ravaglia F, Roperto RM, Farsetti S, Benetti E, Rotondi M, Murer L, Lazzeri E, Lasagni L, Materassi M, Romagnani P (2015) Heterogeneous genetic alterations in sporadic nephrotic syndrome associate with resistance to immunosuppression. J Am Soc Nephrol 26:230\u2013236","journal-title":"J Am Soc Nephrol"},{"key":"4225_CR28","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2215\/CJN.07370715","volume":"11","author":"AK Buscher","year":"2016","unstructured":"Buscher AK, Beck BB, Melk A, Hoefele J, Kranz B, Bamborschke D, Baig S, Lange-Sperandio B, Jungraithmayr T, Weber LT, Kemper MJ, Tonshoff B, Hoyer PF, Konrad M, Weber S, German Pediatric Nephrology Association (2016) Rapid response to cyclosporin a and favorable renal outcome in nongenetic versus genetic steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol 11:245\u2013253","journal-title":"Clin J Am Soc Nephrol"},{"key":"4225_CR29","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1681\/ASN.2016101121","volume":"28","author":"A Trautmann","year":"2017","unstructured":"Trautmann A, Schnaidt S, Lipska-Zietkiewicz BS, Bodria M, Ozaltin F, Emma F, Anarat A, Melk A, Azocar M, Oh J, Saeed B, Gheisari A, Caliskan S, Gellermann J, Higuita LMS, Jankauskiene A, Drozdz D, Mir S, Balat A, Szczepanska M, Paripovic D, Zurowska A, Bogdanovic R, Yilmaz A, Ranchin B, Baskin E, Erdogan O, Remuzzi G, Firszt-Adamczyk A, Kuzma-Mroczkowska E, Litwin M, Murer L, Tkaczyk M, Jardim H, Wasilewska A, Printza N, Fidan K, Simkova E, Borzecka H, Staude H, Hees K, Schaefer F, PodoNet Consortium (2017) Long-term outcome of steroid-resistant nephrotic syndrome in children. J Am Soc Nephrol 28:3055\u20133065","journal-title":"J Am Soc Nephrol"},{"key":"4225_CR30","doi-asserted-by":"publisher","unstructured":"Bensimhon AR, Williams AE, Gbadegesin RA (2018) Treatment of steroid-resistant nephrotic syndrome in the genomic era. Pediatr Nephrol. https:\/\/doi.org\/10.1007\/s00467-018-4093-1","DOI":"10.1007\/s00467-018-4093-1"},{"key":"4225_CR31","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2215\/CJN.04120417","volume":"13","author":"JK Warejko","year":"2018","unstructured":"Warejko JK, Tan W, Daga A, Schapiro D, Lawson JA, Shril S, Lovric S, Ashraf S, Rao J, Hermle T, Jobst-Schwan T, Widmeier E, Majmundar AJ, Schneider R, Gee HY, Schmidt JM, Vivante A, van der Ven AT, Ityel H, Chen J, Sadowski CE, Kohl S, Pabst WL, Nakayama M, Somers MJG, Rodig NM, Daouk G, Baum M, Stein DR, Ferguson MA, Traum AZ, Soliman NA, Kari JA, El Desoky S, Fathy H, Zenker M, Bakkaloglu SA, Muller D, Noyan A, Ozaltin F, Cadnapaphornchai MA, Hashmi S, Hopcian J, Kopp JB, Benador N, Bockenhauer D, Bogdanovic R, Stajic N, Chernin G, Ettenger R, Fehrenbach H, Kemper M, Munarriz RL, Podracka L, Buscher R, Serdaroglu E, Tasic V, Mane S, Lifton RP, Braun DA, Hildebrandt F (2018) Whole exome sequencing of patients with steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol 13:53\u201362","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"4225_CR32","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s00467-018-3963-x","volume":"34","author":"Georges Desch\u00eanes","year":"2018","unstructured":"Desch\u00eanes G, Dossier C, Hogan J (2018) Treating the idiopathic nephrotic syndrome: are steroids the answer? Pediatr Nephrol. https:\/\/doi.org\/10.1007\/s00467-018-3963-x","journal-title":"Pediatric Nephrology"},{"key":"4225_CR33","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.2215\/CJN.01920218","volume":"13","author":"JA Jefferson","year":"2018","unstructured":"Jefferson JA (2018) Complications of immunosuppression in glomerular disease. Clin J Am Soc Nephrol 13:1264\u20131275","journal-title":"Clin J Am Soc Nephrol"},{"key":"4225_CR34","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3389\/fped.2018.00200","volume":"6","author":"A Trautmann","year":"2018","unstructured":"Trautmann A, Lipska-Zietkiewicz BS, Schaefer F (2018) Exploring the clinical and genetic spectrum of steroid resistant nephrotic syndrome: the PodoNet Registry. Front Pediatr 6:200","journal-title":"Front Pediatr"},{"key":"4225_CR35","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.2215\/CJN.01190210","volume":"5","author":"AK Buscher","year":"2010","unstructured":"Buscher AK, Kranz B, Buscher R, Hildebrandt F, Dworniczak B, Pennekamp P, Kuwertz-Broking E, Wingen AM, John U, Kemper M, Monnens L, Hoyer PF, Weber S, Konrad M (2010) Immunosuppression and renal outcome in congenital and pediatric steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol 5:2075\u20132084","journal-title":"Clin J Am Soc Nephrol"},{"key":"4225_CR36","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00467-009-1356-x","volume":"25","author":"VR Mello de","year":"2010","unstructured":"de Mello VR, Rodrigues MT, Mastrocinque TH, Martins SP, de Andrade OV, Guidoni EB, Scheffer DK, Martini Filho D, Toporovski J, Benini V (2010) Mycophenolate mofetil in children with steroid\/cyclophosphamide-resistant nephrotic syndrome. Pediatr Nephrol 25:453\u2013460","journal-title":"Pediatr Nephrol"},{"key":"4225_CR37","first-page":"CD003594","volume":"11","author":"EM Hodson","year":"2010","unstructured":"Hodson EM, Willis NS, Craig JC (2010) Interventions for idiopathic steroid-resistant nephrotic syndrome in children. Cochrane Database Syst Rev 11:CD003594","journal-title":"Cochrane Database Syst Rev"},{"key":"4225_CR38","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1007\/s00467-009-1264-0","volume":"24","author":"Y Hamasaki","year":"2009","unstructured":"Hamasaki Y, Yoshikawa N, Hattori S, Sasaki S, Iijima K, Nakanishi K, Matsuyama T, Ishikura K, Yata N, Kaneko T, Honda M, Japanese Study Group of Renal Disease (2009) Cyclosporine and steroid therapy in children with steroid-resistant nephrotic syndrome. Pediatr Nephrol 24:2177\u20132185","journal-title":"Pediatr Nephrol"},{"key":"4225_CR39","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1681\/ASN.2011080775","volume":"23","author":"A Magnasco","year":"2012","unstructured":"Magnasco A, Ravani P, Edefonti A, Murer L, Ghio L, Belingheri M, Benetti E, Murtas C, Messina G, Massella L, Porcellini MG, Montagna M, Regazzi M, Scolari F, Ghiggeri GM (2012) Rituximab in children with resistant idiopathic nephrotic syndrome. J Am Soc Nephrol 23:1117\u20131124","journal-title":"J Am Soc Nephrol"},{"key":"4225_CR40","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1001\/jamapediatrics.2018.1323","volume":"172","author":"B Basu","year":"2018","unstructured":"Basu B, Sander A, Roy B, Preussler S, Barua S, Mahapatra TKS, Schaefer F (2018) Efficacy of rituximab vs tacrolimus in pediatric corticosteroid-dependent nephrotic syndrome: a randomized clinical trial. JAMA Pediatr 172:757\u2013764","journal-title":"JAMA Pediatr"},{"key":"4225_CR41","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nm.1857","volume":"14","author":"C Faul","year":"2008","unstructured":"Faul C, Donnelly M, Merscher-Gomez S, Chang YH, Franz S, Delfgaauw J, Chang JM, Choi HY, Campbell KN, Kim K, Reiser J, Mundel P (2008) The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med 14:931\u2013938","journal-title":"Nat Med"},{"key":"4225_CR42","doi-asserted-by":"crossref","first-page":"C558","DOI":"10.1152\/ajpcell.00077.2008","volume":"296","author":"J Schlondorff","year":"2009","unstructured":"Schlondorff J, Del Camino D, Carrasquillo R, Lacey V, Pollak MR (2009) TRPC6 mutations associated with focal segmental glomerulosclerosis cause constitutive activation of NFAT-dependent transcription. Am J Physiol Cell Physiol 296:C558\u2013C569","journal-title":"Am J Physiol Cell Physiol"},{"key":"4225_CR43","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1681\/ASN.2009121253","volume":"21","author":"Y Wang","year":"2010","unstructured":"Wang Y, Jarad G, Tripathi P, Pan M, Cunningham J, Martin DR, Liapis H, Miner JH, Chen F (2010) Activation of NFAT signaling in podocytes causes glomerulosclerosis. J Am Soc Nephrol 21:1657\u20131666","journal-title":"J Am Soc Nephrol"},{"key":"4225_CR44","doi-asserted-by":"crossref","first-page":"85ra46","DOI":"10.1126\/scitranslmed.3002231","volume":"3","author":"A Fornoni","year":"2011","unstructured":"Fornoni A, Sageshima J, Wei C, Merscher-Gomez S, Aguillon-Prada R, Jauregui AN, Li J, Mattiazzi A, Ciancio G, Chen L, Zilleruelo G, Abitbol C, Chandar J, Seeherunvong W, Ricordi C, Ikehata M, Rastaldi MP, Reiser J, Burke GW 3rd (2011) Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis. Sci Transl Med 3:85ra46","journal-title":"Sci Transl Med"},{"key":"4225_CR45","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0272-6386(99)70299-4","volume":"33","author":"A Fassi","year":"1999","unstructured":"Fassi A, Sangalli F, Colombi F, Perico N, Remuzzi G, Remuzzi A (1999) Beneficial effects of calcium channel blockade on acute glomerular hemodynamic changes induced by cyclosporine. Am J Kidney Dis 33:267\u2013275","journal-title":"Am J Kidney Dis"},{"key":"4225_CR46","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2215\/CJN.12991117","volume":"13","author":"C Ponticelli","year":"2018","unstructured":"Ponticelli C, Locatelli F (2018) Glucocorticoids in the treatment of glomerular diseases: pitfalls and pearls. Clin J Am Soc Nephrol 13:815\u2013822","journal-title":"Clin J Am Soc Nephrol"},{"key":"4225_CR47","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1681\/ASN.2005020142","volume":"16","author":"T Wada","year":"2005","unstructured":"Wada T, Pippin JW, Marshall CB, Griffin SV, Shankland SJ (2005) Dexamethasone prevents podocyte apoptosis induced by puromycin aminonucleoside: role of p53 and Bcl-2-related family proteins. J Am Soc Nephrol 16:2615\u20132625","journal-title":"J Am Soc Nephrol"},{"key":"4225_CR48","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1159\/000131892","volume":"109","author":"T Wada","year":"2008","unstructured":"Wada T, Pippin JW, Nangaku M, Shankland SJ (2008) Dexamethasone\u2019s prosurvival benefits in podocytes require extracellular signal-regulated kinase phosphorylation. Nephron Exp Nephrol 109:e8\u2013e19","journal-title":"Nephron Exp Nephrol"},{"key":"4225_CR49","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1042\/CS20140749","volume":"128","author":"L Jiang","year":"2015","unstructured":"Jiang L, Dasgupta I, Hurcombe JA, Colyer HF, Mathieson PW, Welsh GI (2015) Levamisole in steroid-sensitive nephrotic syndrome: usefulness in adult patients and laboratory insights into mechanisms of action via direct action on the kidney podocyte. Clin Sci 128:883\u2013893","journal-title":"Clin Sci"},{"key":"4225_CR50","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s00467-015-3109-3","volume":"30","author":"I Klaassen","year":"2015","unstructured":"Klaassen I, Ozgoren B, Sadowski CE, Moller K, van Husen M, Lehnhardt A, Timmermann K, Freudenberg F, Helmchen U, Oh J, Kemper MJ (2015) Response to cyclosporine in steroid-resistant nephrotic syndrome: discontinuation is possible. Pediatr Nephrol 30:1477\u20131483","journal-title":"Pediatr Nephrol"},{"key":"4225_CR51","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/ng1918","volume":"38","author":"B Hinkes","year":"2006","unstructured":"Hinkes B, Wiggins RC, Gbadegesin R, Vlangos CN, Seelow D, Nurnberg G, Garg P, Verma R, Chaib H, Hoskins BE, Ashraf S, Becker C, Hennies HC, Goyal M, Wharram BL, Schachter AD, Mudumana S, Drummond I, Kerjaschki D, Waldherr R, Dietrich A, Ozaltin F, Bakkaloglu A, Cleper R, Basel-Vanagaite L, Pohl M, Griebel M, Tsygin AN, Soylu A, Muller D, Sorli CS, Bunney TD, Katan M, Liu J, Attanasio M, O\u2019Toole JF, Hasselbacher K, Mucha B, Otto EA, Airik R, Kispert A, Kelley GG, Smrcka AV, Gudermann T, Holzman LB, Nurnberg P, Hildebrandt F (2006) Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible. Nat Genet 38:1397\u20131405","journal-title":"Nat Genet"},{"key":"4225_CR52","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/ki.2013.519","volume":"85","author":"BS Lipska","year":"2014","unstructured":"Lipska BS, Ranchin B, Iatropoulos P, Gellermann J, Melk A, Ozaltin F, Caridi G, Seeman T, Tory K, Jankauskiene A, Zurowska A, Szczepanska M, Wasilewska A, Harambat J, Trautmann A, Peco-Antic A, Borzecka H, Moczulska A, Saeed B, Bogdanovic R, Kalyoncu M, Simkova E, Erdogan O, Vrljicak K, Teixeira A, Azocar M, Schaefer F, PodoNet Consortium (2014) Genotype-phenotype associations in WT1 glomerulopathy. Kidney Int 85:1169\u20131178","journal-title":"Kidney Int"},{"key":"4225_CR53","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1172\/JCI69134","volume":"123","author":"HY Gee","year":"2013","unstructured":"Gee HY, Saisawat P, Ashraf S, Hurd TW, Vega-Warner V, Fang H, Beck BB, Gribouval O, Zhou W, Diaz KA, Natarajan S, Wiggins RC, Lovric S, Chernin G, Schoeb DS, Ovunc B, Frishberg Y, Soliman NA, Fathy HM, Goebel H, Hoefele J, Weber LT, Innis JW, Faul C, Han Z, Washburn J, Antignac C, Levy S, Otto EA, Hildebrandt F (2013) ARHGDIA mutations cause nephrotic syndrome via defective RHO GTPase signaling. J Clin Invest 123:3243\u20133253","journal-title":"J Clin Invest"},{"key":"4225_CR54","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1681\/ASN.2014050489","volume":"26","author":"CE Sadowski","year":"2015","unstructured":"Sadowski CE, Lovric S, Ashraf S, Pabst WL, Gee HY, Kohl S, Engelmann S, Vega-Warner V, Fang H, Halbritter J, Somers MJ, Tan W, Shril S, Fessi I, Lifton RP, Bockenhauer D, El-Desoky S, Kari JA, Zenker M, Kemper MJ, Mueller D, Fathy HM, Soliman NA, Hildebrandt F, SRNS Study Group (2015) A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome. J Am Soc Nephrol 26:1279\u20131289","journal-title":"J Am Soc Nephrol"},{"key":"4225_CR55","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s00467-018-3937-z","volume":"33","author":"MC Starr","year":"2018","unstructured":"Starr MC, Chang IJ, Finn LS, Sun A, Larson AA, Goebel J, Hanevold C, Thies J, Van Hove JLK, Hingorani SR, Lam C (2018) COQ2 nephropathy: a treatable cause of nephrotic syndrome in children. Pediatr Nephrol 33:1257\u20131261","journal-title":"Pediatr Nephrol"},{"key":"4225_CR56","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1053\/j.ajkd.2016.10.040","volume":"70","author":"E Park","year":"2017","unstructured":"Park E, Ahn YH, Kang HG, Yoo KH, Won NH, Lee KB, Moon KC, Seong MW, Gwon TR, Park SS, Cheong HI (2017) COQ6 mutations in children with steroid-resistant focal segmental glomerulosclerosis and sensorineural hearing loss. Am J Kidney Dis 70:139\u2013144","journal-title":"Am J Kidney Dis"},{"key":"4225_CR57","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.nmd.2011.05.001","volume":"22","author":"S Rahman","year":"2012","unstructured":"Rahman S, Clarke CF, Hirano M (2012) 176th ENMC International Workshop: diagnosis and treatment of coenzyme Q(1)(0) deficiency. Neuromuscul Disord 22:76\u201386","journal-title":"Neuromuscul Disord"},{"key":"4225_CR58","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/s00467-017-3634-3","volume":"32","author":"M Atmaca","year":"2017","unstructured":"Atmaca M, Gulhan B, Korkmaz E, Inozu M, Soylemezoglu O, Candan C, Bayazit AK, Elmaci AM, Parmaksiz G, Duzova A, Besbas N, Topaloglu R, Ozaltin F (2017) Follow-up results of patients with ADCK4 mutations and the efficacy of CoQ10 treatment. Pediatr Nephrol 32:1369\u20131375","journal-title":"Pediatr Nephrol"},{"key":"4225_CR59","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.bbabio.2016.03.036","volume":"1857","author":"MJ Acosta","year":"2016","unstructured":"Acosta MJ, Vazquez Fonseca L, Desbats MA, Cerqua C, Zordan R, Trevisson E, Salviati L (2016) Coenzyme Q biosynthesis in health and disease. Biochim Biophys Acta 1857:1079\u20131085","journal-title":"Biochim Biophys Acta"},{"key":"4225_CR60","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nrneph.2015.214","volume":"12","author":"F Emma","year":"2016","unstructured":"Emma F, Montini G, Parikh SM, Salviati L (2016) Mitochondrial dysfunction in inherited renal disease and acute kidney injury. Nat Rev Nephrol 12:267\u2013280","journal-title":"Nat Rev Nephrol"},{"key":"4225_CR61","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1056\/NEJMc0800582","volume":"358","author":"G Montini","year":"2008","unstructured":"Montini G, Malaventura C, Salviati L (2008) Early coenzyme Q10 supplementation in primary coenzyme Q10 deficiency. N Engl J Med 358:2849\u20132850","journal-title":"N Engl J Med"},{"key":"4225_CR62","doi-asserted-by":"crossref","unstructured":"Kemper MJ, Valentin L, van Husen M (2017) Difficult-to-treat idiopathic nephrotic syndrome: established drugs, open questions and future options. Pediatr Nephrol","DOI":"10.1007\/s00467-017-3780-7"},{"key":"4225_CR63","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.trsl.2008.04.001","volume":"151","author":"VJ Savin","year":"2008","unstructured":"Savin VJ, McCarthy ET, Sharma R, Charba D, Sharma M (2008) Galactose binds to focal segmental glomerulosclerosis permeability factor and inhibits its activity. Transl Res 151:288\u2013292","journal-title":"Transl Res"},{"key":"4225_CR64","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1093\/ndt\/gfp278","volume":"24","author":"E Smet De","year":"2009","unstructured":"De Smet E, Rioux JP, Ammann H, Deziel C, Querin S (2009) FSGS permeability factor-associated nephrotic syndrome: remission after oral galactose therapy. Nephrol Dial Transplant 24:2938\u20132940","journal-title":"Nephrol Dial Transplant"},{"key":"4225_CR65","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1744-9987.2011.00949.x","volume":"15","author":"M Kopac","year":"2011","unstructured":"Kopac M, Meglic A, Rus RR (2011) Partial remission of resistant nephrotic syndrome after oral galactose therapy. Ther Apher Dial 15:269\u2013272","journal-title":"Ther Apher Dial"},{"key":"4225_CR66","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1681\/ASN.2009101025","volume":"21","author":"A Lindskog","year":"2010","unstructured":"Lindskog A, Ebefors K, Johansson ME, Stefansson B, Granqvist A, Arnadottir M, Berg AL, Nystrom J, Haraldsson B (2010) Melanocortin 1 receptor agonists reduce proteinuria. J Am Soc Nephrol 21:1290\u20131298","journal-title":"J Am Soc Nephrol"},{"key":"4225_CR67","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1053\/j.ackd.2013.09.004","volume":"21","author":"R Gong","year":"2014","unstructured":"Gong R (2014) Leveraging melanocortin pathways to treat glomerular diseases. Adv Chronic Kidney Dis 21:134\u2013151","journal-title":"Adv Chronic Kidney Dis"},{"key":"4225_CR68","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/ki.2011.105","volume":"80","author":"J Oh","year":"2011","unstructured":"Oh J, Beckmann J, Bloch J, Hettgen V, Mueller J, Li L, Hoemme M, Gross ML, Penzel R, Mundel P, Schaefer F, Schmitt CP (2011) Stimulation of the calcium-sensing receptor stabilizes the podocyte cytoskeleton, improves cell survival, and reduces toxin-induced glomerulosclerosis. Kidney Int 80:483\u2013492","journal-title":"Kidney Int"},{"key":"4225_CR69","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/nrd2685","volume":"7","author":"N Perico","year":"2008","unstructured":"Perico N, Benigni A, Remuzzi G (2008) Present and future drug treatments for chronic kidney diseases: evolving targets in renoprotection. Nat Rev Drug Discov 7:936\u2013953","journal-title":"Nat Rev Drug Discov"},{"key":"4225_CR70","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1097\/01.ASN.0000127988.42710.A7","volume":"15","author":"S Hoffmann","year":"2004","unstructured":"Hoffmann S, Podlich D, Hahnel B, Kriz W, Gretz N (2004) Angiotensin II type 1 receptor overexpression in podocytes induces glomerulosclerosis in transgenic rats. J Am Soc Nephrol 15:1475\u20131487","journal-title":"J Am Soc Nephrol"},{"key":"4225_CR71","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1523-1755.2004.00362.x","volume":"65","author":"RV Durvasula","year":"2004","unstructured":"Durvasula RV, Petermann AT, Hiromura K, Blonski M, Pippin J, Mundel P, Pichler R, Griffin S, Couser WG, Shankland SJ (2004) Activation of a local tissue angiotensin system in podocytes by mechanical strain. Kidney Int 65:30\u201339","journal-title":"Kidney Int"},{"key":"4225_CR72","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1007\/s00467-013-2539-z","volume":"28","author":"K Sgambat","year":"2013","unstructured":"Sgambat K, Banks M, Moudgil A (2013) Effect of galactose on glomerular permeability and proteinuria in steroid-resistant nephrotic syndrome. Pediatr Nephrol 28:2131\u20132135","journal-title":"Pediatr Nephrol"},{"key":"4225_CR73","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12882-015-0094-5","volume":"16","author":"H Trachtman","year":"2015","unstructured":"Trachtman H, Vento S, Herreshoff E, Radeva M, Gassman J, Stein DT, Savin VJ, Sharma M, Reiser J, Wei C, Somers M, Srivastava T, Gipson DS (2015) Efficacy of galactose and adalimumab in patients with resistant focal segmental glomerulosclerosis: report of the font clinical trial group. BMC Nephrol 16:111","journal-title":"BMC Nephrol"},{"key":"4225_CR74","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1093\/ndt\/gfh110","volume":"19","author":"AL Berg","year":"2004","unstructured":"Berg AL, Arnadottir M (2004) ACTH-induced improvement in the nephrotic syndrome in patients with a variety of diagnoses. Nephrol Dial Transplant 19:1305\u20131307","journal-title":"Nephrol Dial Transplant"},{"key":"4225_CR75","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.2215\/CJN.02840313","volume":"8","author":"J Hogan","year":"2013","unstructured":"Hogan J, Bomback AS, Mehta K, Canetta PA, Rao MK, Appel GB, Radhakrishnan J, Lafayette RA (2013) Treatment of idiopathic FSGS with adrenocorticotropic hormone gel. Clin J Am Soc Nephrol 8:2072\u20132081","journal-title":"Clin J Am Soc Nephrol"},{"key":"4225_CR76","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1093\/ndt\/gfu069","volume":"29","author":"MA Hladunewich","year":"2014","unstructured":"Hladunewich MA, Cattran D, Beck LH, Odutayo A, Sethi S, Ayalon R, Leung N, Reich H, Fervenza FC (2014) A pilot study to determine the dose and effectiveness of adrenocorticotrophic hormone (H.P. Acthar(R) Gel) in nephrotic syndrome due to idiopathic membranous nephropathy. Nephrol Dial Transplant 29:1570\u20131577","journal-title":"Nephrol Dial Transplant"},{"key":"4225_CR77","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s40620-016-0308-3","volume":"30","author":"KV Lieberman","year":"2017","unstructured":"Lieberman KV, Pavlova-Wolf A (2017) Adrenocorticotropic hormone therapy for the treatment of idiopathic nephrotic syndrome in children and young adults: a systematic review of early clinical studies with contemporary relevance. J Nephrol 30:35\u201344","journal-title":"J Nephrol"},{"key":"4225_CR78","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/ckj\/sfw045","volume":"9","author":"W Kittanamongkolchai","year":"2016","unstructured":"Kittanamongkolchai W, Cheungpasitporn W, Zand L (2016) Efficacy and safety of adrenocorticotropic hormone treatment in glomerular diseases: a systematic review and meta-analysis. Clin Kidney J 9:387\u2013396","journal-title":"Clin Kidney J"},{"key":"4225_CR79","doi-asserted-by":"crossref","first-page":"21","DOI":"10.5414\/CN108915","volume":"2017","author":"J Deng","year":"2017","unstructured":"Deng J, Zheng X, Xie H, Chen L (2017) Calcitriol in the treatment of IgA nephropathy with non-nephrotic range proteinuria: a meta-analysis of randomized controlled trials. Clin Nephrol 2017:21\u201327","journal-title":"Clin Nephrol"},{"key":"4225_CR80","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1007\/s00467-013-2511-y","volume":"28","author":"S Banerjee","year":"2013","unstructured":"Banerjee S, Basu S, Sengupta J (2013) Vitamin D in nephrotic syndrome remission: a case-control study. Pediatr Nephrol 28:1983\u20131989","journal-title":"Pediatr Nephrol"},{"key":"4225_CR81","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/ckj\/sfx099","volume":"11","author":"H Hara","year":"2018","unstructured":"Hara H, Hirano D (2018) Azithromycin suppressed relapses of idiopathic nephrotic syndrome in a child. Clin Kidney J 11:54\u201355","journal-title":"Clin Kidney J"},{"key":"4225_CR82","doi-asserted-by":"crossref","first-page":"F655","DOI":"10.1152\/ajprenal.00373.2009","volume":"298","author":"A Whaley-Connell","year":"2010","unstructured":"Whaley-Connell A, Nistala R, Habibi J, Hayden MR, Schneider RI, Johnson MS, Tilmon R, Rehmer N, Ferrario CM, Sowers JR (2010) Comparative effect of direct renin inhibition and AT1R blockade on glomerular filtration barrier injury in the transgenic Ren2 rat. Am J Physiol Renal Physiol 298:F655\u2013F661","journal-title":"Am J Physiol Renal Physiol"},{"key":"4225_CR83","first-page":"CD003594","volume":"10","author":"EM Hodson","year":"2016","unstructured":"Hodson EM, Wong SC, Willis NS, Craig JC (2016) Interventions for idiopathic steroid-resistant nephrotic syndrome in children. Cochrane Database Syst Rev 10:CD003594","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"4225_CR84","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1681\/ASN.2018010091","volume":"29","author":"Howard Trachtman","year":"2018","unstructured":"Trachtman H, Nelson P, Adler S, Campbell KN, Chaudhuri A, Derebail VK, Gambaro G, Gesualdo L, Gipson DS, Hogan J, Lieberman K, Marder B, Meyers KE, Mustafa E, Radhakrishnan J, Srivastava T, Stepanians M, Tesar V, Zhdanova O, Komers R, Group DS (2018) DUET: A Phase 2 Study evaluating the efficacy and safety of sparsentan in patients with FSGS. J Am Soc Nephrol\u00a0 29:2745\u20132754","journal-title":"Journal of the American Society of Nephrology"},{"issue":"4","key":"4225_CR85","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.ekir.2017.02.019","volume":"2","author":"Radko Komers","year":"2017","unstructured":"\u00a0Komers R, Gipson DS, Nelson P, Adler S, Srivastava T, Derebail VK, Meyers KE, Pergola P, MacNally ME, Hunt JL, Shih A,\u00a0Trachtman H (2017) Efficacy and safety of sparsentan compared with irbesartan in patients with primary focal segmental\u00a0glomerulosclerosis: randomized, controlled trial design (DUET).\u00a0Kidney Int Rep 2:654\u2013664.\u00a0","journal-title":"Kidney International Reports"},{"key":"4225_CR86","doi-asserted-by":"crossref","unstructured":"Wang XQ,Wang L, Tu YC, Zhang YC (2018) Traditional Chinese medicine for refractory nephrotic syndrome: strategies and promising treatments. Evid Based Complement Alternat Med 2018: 8746349","DOI":"10.1155\/2018\/8746349"},{"key":"4225_CR87","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1124\/dmd.112.050302","volume":"41","author":"H Wei","year":"2013","unstructured":"Wei H, Tao X, Di P, Yang Y, Li J, Qian X, Feng J, Chen W (2013) Effects of traditional Chinese medicine Wuzhi capsule on pharmacokinetics of tacrolimus in rats. Drug Metab Dispos 41:1398\u20131403.","journal-title":"Drug Metab Dispos"},{"issue":"10","key":"4225_CR88","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s11255-014-0801-3","volume":"46","author":"Zhanfeng Sun","year":"2014","unstructured":"Sun Z, Ren M, Wu Q, Du X (2014) Co-administration of Wuzhi capsules and tacrolimus in patients with idiopathic membranous nephropathy: clinical efficacy and pharmacoeconomics. Int Urol Nephrol 46:1977\u20131982","journal-title":"International Urology and Nephrology"},{"key":"4225_CR89","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1053\/j.ajkd.2015.04.013","volume":"66","author":"Y Zhong","year":"2015","unstructured":"Zhong Y, Menon MC, Deng Y, Chen Y, He JC (2015) Recent advances in traditional Chinese medicine for kidney disease. Am J Kidney Dis 66:513\u2013515","journal-title":"Am J Kidney Dis"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-019-04225-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-019-04225-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-019-04225-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T07:30:09Z","timestamp":1663140609000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-019-04225-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,23]]},"references-count":89,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["4225"],"URL":"https:\/\/doi.org\/10.1007\/s00467-019-04225-7","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,23]]},"assertion":[{"value":"12 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}